Discover 476 paid clinical trials in Grand Rapids, Michigan. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 476
Neoadjuvant Darovasertib in Primary Uveal Melanoma
for
Uveal Melanoma
Location: Grand Rapids MI, Toronto, Rochester MN, Nashville TN,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07015190
Phase3, Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
for
Metastatic Solid Tumor, Recurrent Solid Tumor,
Location: Grand Rapids MI, Chicago IL, Cleveland OH, St Louis MO,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06465069
Phase1, Recruiting
Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
for
Limited-stage Small Cell Lung Cancer (LS-SCLC)
Location: Grand Rapids MI, Toledo OH, Bethesda MD, Orange City FL,
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Sex: All
Age: 18+
Code: NCT06095583
Phase3, Recruiting
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Grand Rapids MI, Milwaukee WI, Detroit MI, Carmel IN,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136650
Phase3, Recruiting
To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumors
Location: Grand Rapids MI, Avon IN, Toronto, Nashville TN,
Sponsor: Day One Biopharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT06752681
Phase1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
for
Neoplasms
Location: Grand Rapids MI, Chicago IL, San Antonio TX,
Sponsor: Corcept Therapeutics
Sex: All
Age: 18+
Code: NCT07276373
Phase1, Phase2, Recruiting
A Study of YL242 in Subjects With Advanced Solid Tumors
for
Advanced Solid Tumor
Location: Grand Rapids MI, Nashville TN, Sarasota FL
Sponsor: MediLink Therapeutics (Suzhou) Co., Ltd.
Sex: All
Age: 18+
Code: NCT07197827
Phase1, Phase2, Recruiting
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
for
Solid Tumors
Location: Grand Rapids MI, Detroit MI, Naperville IL, Madison WI,
Sponsor: Incyte Corporation
Sex: All
Age: 18+
Code: NCT07522073
Phase3, Recruiting
This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic Treatment
for
Atopic Dermatitis
Location: Caledonia MI, Bay City MI, Ann Arbor MI, Waterford MI,
Sponsor: Sanofi
Sex: All
Age: 12+
Code: NCT07290803
Recruiting
Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis Flares
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
for
Prurigo Nodularis (PN)
Location: Caledonia MI, Auburn Hills MI, Troy MI, Indianapolis IN,
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Sex: All
Age: 18 - 70+
Code: NCT07236099
Phase2, Recruiting
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
for
Chronic Spontaneous Urticaria (CSU)
Location: Caledonia MI, Ann Arbor MI, Chicago IL, Skokie IL,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06868212
Phase3, Recruiting
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
for
Atopic Dermatitis
Location: Caledonia MI, Chicago IL, Indianapolis IN, Dayton OH,
Sponsor: Galderma R&D
Sex: All
Age: 12+
Code: NCT06988605
Recruiting
Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: Holland MI, Shiloh IL, Florissant MO, St Louis MO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase3, Recruiting
A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma
for
Gastroesophageal Adenocarcinoma
Location: North Shores MI, Washington D.C. DC, Fairway KS,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07069712
Phase2, Recruiting
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
for
Monoclonal Gammopathy of Undetermined Significance (MGUS),
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Kalamazoo MI, Chicago IL, Arlington Heights IL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213804
Phase3, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
for
Locally Advanced Cervical Adenocarcinoma,
Location: Kalamazoo MI, Lansing MI, Chelsea MI, Brighton MI,
Sponsor: National Cancer Institute (NCI)
Sex: Female
Age: 18+
Code: NCT07061977
Phase3, Recruiting
Use of Stratafix Symmetric™ to Prevent Incisional Hernia in Gastrointestinal and Abdominal Surgery